IndustryCompany release

Lifeward Q3 revenue falls 12% as AlterG grows and ReWalk moves to channel partners

🇺🇸 Lifeward Ltd. (LFWD) · Fri 13 Nov 2026

The company reported third-quarter 2026 revenue of $5.4 million, with AlterG up 18% while ReWalk exoskeleton sales declined during its shift away from direct sales.

Lifeward Ltd. reported its third-quarter 2026 results on 13 November, showing revenue of $5.4 million, a fall of 12% compared with the same period a year earlier.

The AlterG business grew 18% year on year to $3.6 million. Sales of the ReWalk exoskeleton fell to $1.7 million, as the company moves from selling directly to relying on channel-partner distribution.

Profitability weakened over the quarter. Gross margin came in at 27.4% and the net loss was $5.1 million. Unrestricted cash stood at $4.5 million at the end of the period.

The summary available does not give further detail on the pace of the ReWalk transition, margin drivers or the company's outlook, so it is unclear how quickly the distribution change might affect future results.

What it means for your team

  • Market-access teams following powered exoskeletons should note that ReWalk is being distributed increasingly through channel partners rather than direct sales, which may change who customers and payers deal with.
  • Quality and regulatory teams at distributors may need to review how responsibilities such as complaint handling and post-market surveillance are shared when a manufacturer changes its sales model.
  • The company's reported cash position of $4.5 million and net loss of $5.1 million are figures that counterparties may want to consider in supplier and partner due diligence.

Company's press release (SEC filing): Lifeward Ltd. ↗

Article written by VigiEye from the official source (Lifeward Ltd.). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →